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B Cell Responses to a Peptide Epitope. VI. The Kinetics of
Antigen Recognition Modulates B Cell-Mediated Recruitment
of T Helper Subsets
Lalitha Vijayakrishnan, Venkatasamy Manivel, and Kanury V. S. Rao1
The ability of Ag-primed B cells to recruit distinct Th subsets was examined using two analogous synthetic peptides, G41CT3 and
G28CT3, as model Ags. With sequence differences at only two positions, these peptides were identical both with respect to fine
specificity of Abs induced and ability to prime T cells. Lymph node cell populations primed with peptide G41CT3, when challenged
with the homologous Ag, yielded predominantly Th2 cytokines. In contrast, a challenge with the heterologous Ag, G28CT3,
resulted in a markedly increased production of Th1 cytokines. These distinctions derived from altered APC function of Ag-primed
B cells due to differential kinetics of recognition of the two Ags by surface Ig receptors, as confirmed by binding studies with a
panel of anti-G41CT3 mAbs. A concentration-dependent circular dichroism study revealed differences in the nature of intermo-
lecular associations for these two peptides. Furthermore, the on-rate of peptide G28CT3 binding to Ab also increased with
increasing peptide concentration, implying a dependence on intermolecular interactions. This, in turn, correlated well with the
ability of peptide G28CT3 to preferentially activate either Th1 or Th2 cells. Thus, the relative proportion of Th1 vs Th2 cells
recruited by Ag-primed B cells is governed by the on-rate of Ag binding to surface Ig receptors, with higher on-rates promoting
Th1 recruitment. Further, even subtle changes in solution behavior of an Ag can markedly influence the kinetics of recognition
by B cells. The Journal of Immunology, 1998, 161: 4661–4670.
A cognate interaction between Ag-primed B and T cells iscritical for the sustenance and progression of a T-depen-dent humoral response (1–3). Ags that bind specifically
to surface Ig (sIg)2 receptors on B cells are endocytosed and pro-
cessed, and appropriate fragments are subsequently presented in
the context of MHC class II molecules for recognition by the TCR
on Ag-activated T cells (4). A consequence of this physical inter-
action is the proliferation of both partners and, in addition, differ-
entiation of B cells into Ab-secreting plasmacytes and memory B
cells (1–4).
Earlier studies describing the minimal requirements of ligand
density on the APC surface (5, 6), and the more recent reports
identifying minimal threshold levels of TCR triggering (7, 8) as a
prerequisite for T cell activation collectively suggest that the APC
activity of B cells can be modulated by its ability to bind Ag. Thus,
concentration of free Ag, efficiency of Ag capture, and the effi-
ciency with which the Ag is processed are likely to play important
roles in defining the ability of Ag-activated B cells to present Ag
(4). Our own results have revealed that the APC function of a B
cell, with its consequent effects on Th recruitment capacity, is reg-
ulated by a complexity of parameters that include not only affinity
of sIg receptor for epitope on Ag (9), but also the kinetics of this
interaction (10) and competitive processes between sIg receptor
and secreted Ig for Ag (11). Indeed, it is the collective outcome of
these processes that eventually determines the hierarchy of immu-
nodominance observed against B cell epitopes displayed on mul-
tideterminant Ags (9–13).
The discrimination of effector CD4 T cells into the Th1 and Th2
subsets (14, 15) offers an Ag-presenting B cell the option of se-
lectivity in terms of Th recruitment. While, in principle, such B
cells are known to be capable of interacting with both subsets
(16–18), recent data suggest a preference for activating Th2 cells
(19–21). However, the studies of Murray et al. (22) demonstrating
a key role for ligand density on an APC for determining the rel-
ative extents of Th1 vs Th2 differentiation and activation add yet
another level of intricacy to these issues. This is particularly true
given our earlier findings that the efficiency of an Ag-activated B
cell as APC, also a consequence of ligand density, is a variable that
is under the influence of a variety of factors (9–11). Thus, it is
likely that parameters that regulate Ag recognition by B cells can
also influence the relative extent of Th cells recruited by it.
In this report, we have attempted to address these issues using
two model synthetic peptide immunogens, peptides G28CT3 and
G41CT3. Both peptides shared an identical amino acid sequence
except for variations in two positions. We have earlier shown that
these peptides prime a common pool of Th cells equally well and
that they induce B cells of identical fine specificities, although
peptide G28CT3 is more immunogenic (10). Enhanced immuno-
genicity of peptide G28CT3 could be ascribed to the higher on-rate
of binding to specific B cells relative to peptide G41CT3, which in
turn ensured a more efficient B cell-mediated recruitment of T cell
help (10). Thus, peptides G41CT3 and G28CT3 appeared to rep-
resent useful models for examining the influence of Ag-binding
parameters on selective engagement of Th subsets by activated B
cells. We show here that on-rates of Ag binding to B cells can
regulate the relative proportion of Th1 vs Th2 cells that are re-
cruited by Ag-specific B cells, with a bias toward increased Th1
recruitment at higher on-rates. Further, subtle changes in Ag se-
quence, which do not induce any obvious structural changes, can
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nevertheless dramatically influence the kinetics of Ag recognition
by B cells.
Materials and Methods
Materials
Heavy chain-specific horseradish peroxidase-labeled secondary Abs, goat
anti-mouse IgG1, and goat anti-mouse IgG2a (both heavy chain specific)
were purchased from Sigma Chemical (St. Louis, MO). Magnetic beads for
panning of T and B cells were obtained from Dynal (Oslo, Norway).
ELISA kits for measurement of cytokines were purchased from Genzyme
(Cambridge, MA) and F-moc-amino acid derivatives for peptide synthesis
from Novabiochem (Laufelfingen, Switzerland).
Peptide synthesis
Peptides were synthesized by the solid phase method (23, 24) on a Milli-
pore 9050 automated peptide synthesizer (Millipore, Bedford, MA) using
the F-moc chemistry (25). Crude peptides were purified to at least 95%
purity by reverse phase HPLC on a C-18 column (15 m, d Pak, 19 3 300
mm; Waters, Milford, MA) using an aqueous gradient of 0 to 70% aceto-
nitrile in 0.1% trifluoroacetic acid. Identities of all peptides were ascer-
tained by amino acid analysis.
Animals and immunizations
Female BALB/c mice (6–8 wk old) were obtained from the small animal
breeding facility at the National Institute of Nutrition (Hyderabad, India).
Immunizations were generally given i.p. with a dose of 50 mg/mouse as an
emulsion in CFA (except where otherwise indicated). For polyclonal sera,
mice were bled from the retro-orbital plexus at the indicated times.
Generation of anti-G41CT3 mAbs
Female BALB/c mice immunized with a single dose (50 mg/mouse) of
peptide G41CT3 in CFA were then subsequently boosted i.v. with 50 mg
each of soluble peptide in PBS. Three days later, the highest responder
from the group was taken for the generation of IgG-secreting hybridomas.
Polyethylene glycol-mediated fusion to hypoxanthine-aminopterin-thymi-
dine-sensitive myeloma derivative SP2/O-Ag 14, maintenance of derived
lines, and limiting dilution cloning were essentially as described earlier
(26). The secretion of Ab in culture supernatants was screened by ELISA
against peptide-coated wells, and only wells showing relatively higher Ab
levels (ELISA readings of .1.0) were selected for subcloning and subse-
quent analysis. All of the five IgG mAbs thus obtained were found to be
specific for the DPAF segment (residues 4–7) on peptide G41CT3, as
determined by mapping against an overlapping G41-derived peptide panel
using a protocol that has been previously described (10).
Enzyme-linked immunosorbent assays
Plates were coated with 2 mg of peptide/well in 100 ml of PBS (pH 7.2) at
37°C for 3.5 h. Subsequently, they were blocked with 300 ml/well of a 5%
solution of fat-free dry milk powder in PBS at 37°C for 1 h. Then, 100 ml
of the appropriate dilution of mouse antiserum was added and incubated at
37°C for 1 h. After washing, bound Ab was detected with horseradish
peroxidase-labeled secondary Ab (37°C, 1 h) followed by color develop-
ment with o-phenylenediamine as chromogen. Absorbance was measured
at 490 nm.
For competitive ELISA experiments, antisera were used at dilutions
representing 50% of titer value. Twofold higher concentrations of anti-
serum and competitor peptide were mixed in equal volumes and incubated
for 10 min at room temperature. This was then added to duplicate wells at
100 ml/well. The remaining procedure was as described above.
Enrichment of B cell populations
For enrichment of T cells, lymph node cells (LNCs) from either immune or
nonimmune mice were first depleted of RBCs by lysis with ammonium
chloride, and subsequently adherent cells were removed by panning on
plastic plates at 37°C for 1 h. Nonadherent cells were collected and diluted
to a cell concentration of 5 3 107 cells/ml. B cells were depleted from this
population by two rounds of panning with Dynabeads mouse anti-B220
(4 3 108 beads/ml; Dynal) following the recommended protocol of the
manufacturer.
To obtain enriched B cells, mice immunized with peptide G41CT3 were
boosted 3 wk later with a 50 mg/mouse dose of G41CT3 in PBS given i.v.
Three days later, the spleen was removed and depleted of RBCs, following
which adherent cells were removed by panning as described above. Non-
adherent cells were diluted to 5 3 107 cells/ml, and T cells were depleted
by two rounds of panning with Dynabeads anti-mouse Thy1.2 (4 3 108
beads/ml; Dynal) as recommended by the manufacturer. The resultant en-
riched B cells were then treated with mitomycin C at a final concentration
of 50 mg/ml at 37°C for 20 min. Cells were washed thoroughly in culture
medium before use. When unprimed B cells were required, an identical
protocol was followed except that the splenocytes were taken from non-
immune mice. The purity of B cells obtained by such a protocol was found
to be between 85 and 90% upon analysis by flow cytometry.
Lymphocyte cultures and cytokine estimations
BALB/c mice were immunized s.c. at the tail base with 50 mg/mouse of
peptide G41CT3 as an emulsion in CFA. Seven days later, the mice were
sacrificed and inguinal lymph nodes removed. LNCs, at 5 3 105 cells/well,
were cultured in duplicate in 200 ml of RPMI 1640 containing 10% FCS,
gentamicin (2 mg/L), and 2-ME (0.05 mM) in wells of a 96-well plate. In
addition, the indicated peptide at a final concentration of 30 mM (previ-
ously identified as optimal; Ref.10) was also included as challenge Ag.
Cultures were incubated at 37°C in a humidified atmosphere of 5% carbon
dioxide for 48 h, at which point supernatants were removed for quantitation
of cytokines. Preliminary experiments identified this time point as optimal
for the determination of all relevant cytokines. In experiments employing
enriched B and T cells, cocultures were set up with 2 3 105 cells/well of
each culture.
The cytokines IL-2, IL-4, and IFN-g were measured in a sandwich
ELISA protocol using commercially available kits (Duoset, Genzyme), as
was also IL-10 (Intertest-10x, Genzyme). The recommended protocol of
the manufacturer was followed in all cases, and quantitation was against a
standard curve obtained for individual cytokine standards provided by the
manufacturer, after subtracting background in culture wells where no Ag
was added.
Determination of on-rates
Equal volumes of the appropriate anti-G41CT3 mAb and the relevant pep-
tide were mixed at room temperature, and time-dependent Ab binding in
terms of quenching of tryptophan fluorescence was continuously monitored
over a 100-min period in a Shimadzu RF-1501 spectrofluorometer. The
excitation wavelength used was either 280 or 290 nm, depending on the
Ab, and emission was measured at 330 nm. The final Ab concentration
employed was 200 nm (except where indicated), whereas the peptide con-
centration employed was 20 mM (except where indicated). The extent of
fluorescence quenching was used to determine unbound Ab concentrations
as a function of time; values for kon (association rate constant) were cal-
culated as described earlier (10). Values for kon reported are the mean
(6SD) of three independent determinations.
Results
Peptides G41CT3 and G28CT3
Both peptides G41CT3 and G28CT3 have been described earlier
(10), and their sequences are given in Figure 1. They represent
single amino acid-substituted analogues of a model peptide,
PS1CT3, for which the sequence has also been included in Figure
1 for the sake of comparison. The first 15 residues of peptide
PS1CT3 (segment PS1) represent a known B cell epitope derived
FIGURE 1. The amino acid sequence of peptides G41CT3 and
G28CT3. Both of these peptides represent single amino acid, glycine-sub-
stituted variants of the parent peptide PS1CT3, for which the sequence is
also included for comparison. Peptide G28CT3 is an analogue in which the
amino-terminal histidine residue in PS1CT3 has been substituted with gly-
cine. In peptide G41CT3, the proline residue at position 14 has been sub-
stituted with glycine. The single-letter code for amino acids is used to
describe the sequences, and the glycine substitutions relative to peptide
PS1CT3 are indicated in bold letters. A two-glycine residue spacer between
the B and T cell epitopes that has been used in these peptides (10) is
underlined.
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from the pre-S1 sequence of the hepatitis B surface Ag (27). The
carboxyl-terminal 21-residue sequence (segment CT3) corre-
sponds to the promiscuous Th cell epitope identified from the cir-
cumsporozoite protein of the malaria parasite, Plasmodium falci-
parum (28). Separating the B and T cell epitopes is a spacer of two
glycine residues at positions 16 and 17 (Fig. 1). Peptide G41CT3
is an analogue of peptide PS1CT3 in which the proline residue at
position 14 was substituted by glycine, whereas the amino-termi-
nal histidine residue was substituted for glycine in peptide
G28CT3 (Fig. 1). We have already shown earlier that, akin to
peptide PS1CT3, both peptides G41CT3 and G28CT3 exist pre-
dominantly in a random structure in solution as indicated by their
circular dichroism (CD) spectra (10).
Differential induction of cytokines by peptides G28CT3 and
G41CT3 from G41CT3-primed LNCs
In earlier studies, we showed that, similar to peptide PS1CT3, both
peptides G41CT3 and G28CT3 induce a T-dependent primary B
cell response in BALB/c mice (10). In all three cases, the primary
IgG response was directed, at least predominantly, against a tet-
rapeptide segment between positions four and seven (sequence
DPAF, Fig. 1), indicating that the amino acid variations in peptides
G41CT3 and G28CT3 do not affect the fine specificity of B cells
induced in the primary IgG response (10). Interestingly, however,
peptide G28CT3 was markedly more immunogenic than peptide
G41CT3. This difference in immunogenicity could be ascribed to
the greater ability of peptide G28CT3 to induce a Th cell recall
response by peptide-primed B cells (10). For example, either total
LNCs or enriched splenic B cells from peptide G41CT3-primed
mice gave markedly elevated T cell proliferative responses with
peptide G28CT3 as the challenge Ag relative to that when chal-
lenged with peptide G41CT3. Thus, it was of interest to determine
whether peptides G41CT3 and G28CT3 also showed differences in
relative activation of Ag-specific Th subsets.
Our initial experiments probed for the induction of cytokines
diagnostic of Th1- and Th2-type responses in ex vivo cultures of
LNCs from G41CT3-primed mice, when either peptide G41CT3 or
peptide G28CT3 was added as the challenge Ag. As shown in
Figure 2A, recall of G41CT3-primed LNCs with peptide G41CT3
yielded a cytokine spectrum that was heavily dominated by IL-10,
indicative of a predominantly Th2-type response. In contrast, how-
ever, a challenge with peptide G28CT3 resulted in a five- to six-
fold enhancement in both IL-2 and IFN-g levels, whereas the Th2-
type cytokines IL-4 and IL-10 were relatively unaffected (Fig. 2A).
These results suggest that whereas peptide G41CT3 induces a
dominant recruitment of Th2 effectors from G41CT3-primed
LNCs, recruitment in the presence of peptide G28CT3 is compa-
rably distributed between both Th1 and Th2 subsets from the same
pool.
In parallel experiments, we also examined peptide-modulated
Th recall in LNCs primed with a synthetic peptide representing
only the T cell epitope encoded within the peptides shown in Fig-
ure 1 (segment CT3, the carboxyl-terminal 21 residues). The re-
sults from these set of experiments are shown in Figure 2B. Con-
trary to the results obtained with peptide G41CT3-primed LNCs,
both peptides G28CT3 and G41CT3 induced comparable levels of
all cytokines tested from the CT3-primed LNC population (Fig.
2B). Since the principal difference in the two sets of experiments
described in Figure 2, A and B, was either the inclusion or exclu-
sion of the B cell epitope segment (segment G41) in the priming
immunogen, we thought it possible that the results depicted in
Figure 2A could represent a consequence of Ag-activated B cells
functioning as APCs. Such an inference would also be consistent
with our prior observations on lymphocyte proliferative responses
in G41CT3-primed LNCs with these same peptides (10).
Differential cytokine induction by peptides G41CT3 and
G28CT3 is due to Ag presentation by activated B cells
The experiments described above suggested that the observed dif-
ferences in the cytokine patterns as a result of challenge with either
peptide G41CT3 or G28CT3 of G41CT3-primed LNCs could be
due to B cells functioning as APCs. We examined this possibility
in a relatively more defined experiment in which purified CT3-
primed T cells were cocultured with mitomycin C-treated enriched
splenic B cells from mice primed with peptide G41CT3. These
cultures were then challenged with optimal concentrations of ei-
ther peptide G41CT3 or G28CT3, and the resulting cytokines pro-
duced measured. As shown in Table I, the results obtained here
were entirely consistent with those shown in Figure 2A in that
significantly higher levels of both IL-2 and IFN-g were induced by
G41CT3-primed B cells when G28CT3 was added as challenge Ag
as opposed to when G41CT3 was employed. On the other hand,
IL-4 and IL-10 levels were comparable with both of the challenge
peptides (Table I). In separate experiments, we observed that pre-
treatment of G41CT3-primed B cells with chloroquine (300 mM,
FIGURE 2. Peptides G28CT3 and G41CT3 induce qualitatively differ-
ent T cell recall responses from G41CT3- but not CT3-primed LNCs. Ei-
ther G41CT3 (A)- or CT3 (B)-primed LNCs were cultured in the presence
of an optimal concentration (Materials and Methods) of either peptide
G41CT3 (open bars) or peptide G28CT3 (stippled bars). Subsequently,
production of indicated cytokines in the culture supernatants was measured
as described in Materials and Methods. Values presented are the mean
(6SD) levels obtained from three independent experiments after subtract-
ing the basal values obtained from culture supernatants to which no peptide
was added.
Table I. Peptides G41CT3 and G28CT3 induce differential cytokine
profiles from cocultures of G41CT3-primed B cells and CT3-primed
T cells a
Expt. Recall Ag
Cytokine Levels (pg/ml)
IL-4 IL-10 IL-2 IFN-g
1 G41CT3 ,10 46 30 25
G28CT3 ,10 43 150 150
2 G41CT3 ,10 161 45 63
G28CT3 ,10 160 95 307
3 G41CT3 ,10 197 80 100
G28CT3 ,10 146 320 680
a B cells enriched from splenocytes of G41CT3-immunized mice were cocultured
with enriched T cells derived from lymph nodes of mice primed with peptide CT3 in
the presence of optimal concentrations of either peptide G41CT3 or peptide G28CT3,
as described in Materials and Methods. The resulting cytokines from culture super-
natants were measured by ELISA (Materials and Methods) and the mean of duplicate
wells determined. Results of three separate experiments are shown.
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20 min at 37°) before inclusion in such cultures inhibited both
IFN-g and IL-10 production to barely detectable levels (,15 pg/
ml). This was true regardless of whether peptide G28CT3 or
G41CT3 was used as the challenge Ag (data not shown), implying
that Ag processing and, consequently, its intracellular uptake were
necessary for the differences observed in Table I. Essentially sim-
ilar results were also obtained when G41CT3-primed B cells were
first fixed with 0.1% paraformaldehyde before inclusion in the co-
culture (data not shown), further supporting the view that Ag up-
take and processing are necessary. We also confirmed in these
experiments that the cytokines measured were a product of the
CD41 T cells in selective depletion studies. Thus, while depletion
of CD81 T cells from CT3-primed T cells had no significant effect
on the results shown in Table I, selective CD41 depletion virtually
abrogated the response, reducing the levels of all indicated cyto-
kines to those that were barely detectable (data not shown).
To determine whether Ag priming of B cells was necessary for
the observed effects, we performed experiments in which
unprimed splenic B cells, enriched from naive mice, were cocul-
tured with T cells purified from CT3-primed LNCs before chal-
lenge with either peptide G41CT3 or G28CT3. As shown in Table
II, no significant peptide-mediated differences in cytokine induc-
tion could be observed in such experiments.
Although the data in Tables I and II strongly implied an effect
of Ag presentation mediated by B cells, this conclusion remained
to be rigorously established, particularly considering that the B cell
preparation employed in Table I was only between 85 and 90%
pure. Consequently, the possibility of interference from contami-
nating cell populations could not be ignored. To ascertain this pos-
sibility, the enriched B cell preparation from Table I was further
purified by two rounds of panning against anti-mouse IgG-coated
plates, yielding a B cell preparation between 93 and 96% in purity
with no detectable contamination from either macrophages or den-
dritic cells. However, the results obtained from this additionally
purified B cell preparation were not significantly different from
those shown in Table I (IFN-g/IL-10 ratios between 5 and 7 in
three experiments). This finding further supports the conclusion
that the results in Table I were a consequence of Ag-activated B
cells functioning as APCs.
The observation that differential cytokine induction by the two
analogous peptides was dependent on the inclusion of Ag-primed,
but not unprimed, B cells in the coculture implicated the involve-
ment of B cell Ag receptor (BCR)-mediated uptake of Ag. To
confirm this conjecture, peptide G28CT3 challenge of B-T cocul-
tures was performed as described in Table I, except that varying
concentrations of a peptide representing the B cell epitope segment
of peptide G28CT3 (residues 1–15, segment G28) were also in-
cluded. The latter peptide was added as a competitive inhibitor of
peptide G28CT3 binding to specific BCR (10). Since peptide G28
lacked the T cell epitope, inhibition of peptide G28CT3 recogni-
tion by B cells was also expected to negatively influence T cell
recall responses. As shown in Figure 3A, peptide G28, but not its
scrambled analogue, induced a striking dose-dependent inhibition
of both IFN-g and IL-10 secretion to nearly basal levels at higher
G28 concentrations. This clearly suggests that the induction of
both IFN-g and IL-10 seen in Table I represents the outcome of
BCR-mediated uptake of peptide by Ag-specific B cells, followed
by its presentation to CT3-specific T cells. Also notable was the
observed effect of competitor peptide (G28) concentration on IFN-
g/IL-10 ratios as depicted in Figure 3B. The overwhelming dom-
inance of the Th1 cytokine was found to diminish as peptide G28
concentration increased, implying a relationship between efficacy
of Ag uptake and the relative extent of Th1 vs Th2 stimulation.
Collectively, therefore, the results shown in Tables I and II and
Figure 3 provide evidence to suggest that the observed differential
influence on Th subset stimulation by peptides G41CT3 and
G28CT3 is mediated by activated Ag-specific B cells functioning
as APCs and that these differences probably arise from differences
at the level of BCR-Ag interactions.
Peptides G41CT3 and G28CT3 also induce qualitatively distinct
anamnestic IgG responses from G41CT3-primed B cells
Differential engagement of the Th1 vs the Th2 subsets by activated
B cells has been shown to alter the isotype profile of Abs secreted
by such B cells. This is a result of differential effects of Th1- and
Th2-type cytokines on B cells. Thus, while IFN-g selectively in-
duces secretion of the IgG2aisotype of Abs, IL-4 promotes the
production of the IgG1 isotype (29, 30).
We have shown so far that the relative proportion of Th1 vis a
vis Th2 cells recruited by G41CT3-primed B cells can be influ-
enced by the challenge Ag. It was logical, therefore, to expect that
such Ag-driven differences in Th subset recruitment by primed B
cells should also, in turn, reflect the level of differences in the
proportion of IgG1 vs IgG2a Abs secreted as the outcome of the
B-T cognate interactions. To verify this, we immunized BALB/c
mice with a single dose of peptide G41CT3, and the spleens were
collected 3 wk later. Primed splenocytes were then adoptively
transferred into fresh, irradiated recipients, which were then chal-
lenged with soluble forms of either peptide G41CT3 or G28CT3.
FIGURE 3. Peptide G28CT3-induced T cell recall responses from
G41CT3-primed B cells is mediated by BCR-Ag interactions. Cocultures
of enriched B cells from G41CT3-primed mice and enriched T cells from
CT3-primed mice were challenged with peptide G28CT3 as described in
Table I (A). In addition, indicated concentrations of either peptide G28
(open symbols) or a control peptide of scrambled G28 sequence (closed
symbols; Ref. 10) were also added. Subsequently, supernatants were col-
lected for the measurement of IFN-g (E, F) or IL-10 (, ). B, A replot
of the relevant data shown in A as IFN-g/IL-10 ratios with increasing
peptide G28 concentrations.
Table II. Unprimed B cells do not show peptide-mediated differences
in Th recall a
Expt. Recall Ag
Cytokine Levels (pg/ml)
IL-4 IL-10 IL-2 IFN-g
1 G41CT3 ,10 15 150 273
G28CT3 ,10 15 250 354
2 G41CT3 ,10 114 50 590
G28CT3 ,10 86 85 675
3 G41CT3 ,10 31 60 80
G28CT3 ,10 40 85 120
a The experimental protocol employed here was identical to that described for
Table I except that enriched B cells from splenocytes of unprimed BALB/c mice were
used in this case.
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Relative levels of anamnestic IgG1 and IgG2a titers were then
measured from sera collected 6 days later; the results are summa-
rized in Figure 4. While the IgG1 levels were relatively uninflu-
enced by challenge Ag, serum IgG2a levels were markedly en-
hanced in mice boosted with peptide G28CT3 relative to those
boosted with peptide G41CT3 (Fig. 4). These results further con-
firm, at the functional level, our contention that G41CT3-primed B
cells recruit a larger proportion of Ag-specific Th1 cells when
recalled with peptide G28CT3 as opposed to a restimulation with
peptide G41CT3. Further, this altered recruitment represents a pro-
ductive B-T interaction, with its expected consequences on the
secreted Ab isotype distribution.
Peptides G41CT3 and G28CT3 differ in their on-rates for
binding to anti-G41CT3 mAbs
Results described thus far indicate that G41CT3-primed B cells
recruit a larger proportion of Ag-specific Th1 cells in the presence
of peptide G28CT3 as opposed to peptide G41CT3. This, however,
was not true in the case of either unprimed B cells or CT3-primed
LNCs. Furthermore, we have also previously shown (10) that pep-
tides G41CT3 and G28CT3 do not differ significantly in terms of
processability upon uptake by APCs. Collectively, these data sug-
gested that peptide-dependent differences in specific Ag uptake by
the primed B cell population may account for the observed differ-
ences in interactions with the Th subsets. It was therefore of in-
terest to examine the binding of both peptide G41CT3 and
G28CT3 to the sIg receptors on G41CT3-primed B cells. How-
ever, purification in sufficient quantities and culture of Ag-specific
B cells becomes difficult, particularly in a primary response, given
their low frequencies of occurrence. This is especially true of pep-
tide G41CT3, which has been shown to be poorly immunogenic
(10). Consequently, we decided to employ mAbs generated against
peptide G41CT3 as surrogates for the sIg receptor on G41CT3-
primed B cells. Admittedly, however, the known low frequency of
fusion renders it unlikely that a panel of mAbs generated will be
representative of the actual repertoire of G41CT3-primed B cells
generated in vivo. Nevertheless, results obtained with such mAbs
should prove helpful in identifying a trend, if any exists.
mAbs of the IgG class were obtained from mice immunized
with peptide G41CT3 after boosting with soluble Ag 28 days later.
A total of five highly reactive (Materials and Methods) stabilized
clones were obtained, all of which were found to be specific for the
tetrapeptide sequence DPAF between positions four and seven, as
identified by fine specificity mapping against overlapping
hexapeptides, described earlier (data not shown; Ref. 10). The low
number of hybridomas obtained against peptide G41CT3 is prob-
ably a consequence of its poor immunogenicity (10).
All five of these mAbs were evaluated for their relative affinities
for the homologous peptide G41CT3 and the analogue, peptide
G28CT3, by competitive inhibition ELISA. In addition, we also
measured the on-rates of binding of either peptide to each of these
mAbs in a fluorescence quenching assay under pseudo first order
conditions, as described in Materials and Methods. The results
from both these sets of experiments are summarized in Table III.
All mAbs showed comparable affinities for both peptide G41CT3
and G28CT3, except mAb G41.8 in which the relative affinity for
peptide G41CT3 was marginally higher (Table III). Interestingly,
however, despite the largely comparable affinities, dramatic dif-
ferences in on-rates for binding to the two peptides could be ob-
served. In all cases, on-rates for mAb binding to the heterologous
peptide G28CT3 was markedly higher than that for the homolo-
gous Ag G41CT3, with differences ranging from 3- to as much as
17-fold for mAb G41.8.
Thus, although all obtained anti-G41CT3 mAbs bind both pep-
tides with comparable affinities, the kinetics of this interaction nev-
ertheless differ, with peptide G28CT3 universally displaying a
greater facility for recognition by the paratope of mAbs tested.
Peptides G41CT3 and G28CT3 do not differ in secondary
structural characteristics
An attempt to rationalize the observed differences in the kinetics of
recognition of the two peptides was made by examining the sec-
ondary structural properties by CD spectroscopy. Earlier, such
studies had already revealed an equally random distribution of
conformations in aqueous solution for both peptides (10). Never-
theless, we probed further for any subtle variations in either the
secondary structure or propensities for it, for which purpose we
employed the secondary structure-enhancing solvent, trifluoro-
ethanol (TFE; Ref. 31). Either the whole immunogen molecule
FIGURE 4. Increased production of the IgG2a isotype of Abs on chal-
lenge of G41CT3-primed B cells with peptide G28CT3. Day 21 spleno-
cytes (5 3 107/mouse) from G41CT3-primed mice were injected i.v. in 0.5
ml of PBS into the tail vein of irradiated (550 rad) BALB/c recipients. At
16 h after transfer, the hosts were challenged i.v. with soluble forms of
either peptide G41CT3 or G28CT3 (50 mg/mouse) in sterile PBS. An ad-
ditional control Ag, V3 MNCT3, was also included; V3 MN represents a
15-amino acid residue sequence derived from the V3 loop of the MN
isolate of HIV-1 (sequence RKRIHIGPGRAFYTT). Blood was collected 6
days after antigenic challenge, and relative levels of peptide-specific IgG1
and IgG2a isotype of Abs were determined by quantitative ELISA using
total mouse IgG as standard. A parallel set in which naive splenocytes were
transferred did not yield any IgG response on antigenic challenge, and
neither did the group that was challenged with peptide V3 MNCT3, at least
at the time point tested. Values shown are for individual mice from one of
two independent experiments. Finally, as shown earlier (10), in these ex-
periments the total anti-peptide IgG obtained was three- to fourfold higher
with peptide G28CT3 than with peptide G41CT3 as challenge Ag.
Table III. Affinity and on-rates of peptide G41CT3 and peptide
G28CT3 binding to anti-G41CT3 mAbs a
mAb
IC50 (mM) with Peptide: kon (M21s21) 3 1026 with Peptide:
G41CT3 G28CT3 G41CT3 G28CT3
G41.4 84 6 16 110 6 22 0.7 6 0.2 10.4 6 1.2
G41.8 8 6 3 18 6 4 0.5 6 0.1 8.6 6 0.3
G41.14 80 6 7 75 6 10 2.2 6 0.3 19.7 6 0.5
G41.15 107 6 12 109 6 14 1.0 6 0.1 3.0 6 0.2
G41.16 4 6 2 3 6 1 0.5 6 01 1.6 6 0.2
a IC50 values (competitor concentration required to achieve 50% inhibition of Ab
binding) of individual anti-G41CT3 mAb binding to either peptide was determined by
competitive inhibition ELISA, whereas kon (association rate constant) values were
obtained from fluorescence quenching measurements (Materials and Methods). For
both cases, values presented are the mean (6SD) of at least three independent ex-
periments.
4665The Journal of Immunology
 o
n
 M
ay 26, 2011
w
w
w
.jimmunol.org
D
ow
nloaded from
 
(i.e., G41CT3 or G28CT3) or synthetic peptides representing only
the B epitope segments (residues 1–15, G41 or G28) or the T cell
epitope segment (residues 18–38, peptide CT3) were carefully ex-
amined for their CD spectra in the presence of varying concentra-
tions of TFE. However, such studies again proved unproductive in
that no marked distinctions could be discerned. Thus, while both
peptides G41CT3 and G28CT3 showed increased, but comparable,
helical content with increasing TFE concentrations, this increase
proved to result entirely from the CT3 segment (data not shown).
The B epitope segments (G41 and G28), however, were equally
resistant toward inducibility into any secondary structure, even at
TFE concentrations as high as 50% (data not shown).
Peptides G41CT3 and G28CT3 show altered solution behavior
In contrast to the results described above, an analysis of the CD
spectra as a function of increasing peptide concentration proved
interesting. Such studies revealed a shift in the minima of the neg-
ative peak to longer wavelengths (Fig. 5, A and B). Such a right-
ward shift at higher concentrations is usually indicative of the pres-
ence of intermolecular associations. This association, however, did
not represent peptide aggregation—at least in the sense that it is
generally understood—in that a simple dilution was sufficient to
regenerate the profile obtained at lower concentrations for both
peptides. Thus, dilution from a 60-mM peptide solution to concen-
trations of either 20 or 6 mM readily reproduced the spectra de-
picted in Figure 5, A and B, for the corresponding concentrations.
The intermolecular associations observed at higher concentrations,
therefore, apparently represent weak interactions.
We next probed for the nature of these interactions by examin-
ing the effect of adding salt on the right shift seen at higher peptide
concentrations. For this experiment, solutions of peptide G41CT3
and G28CT3 at a concentration of 60 mM were prepared either in
the presence or absence of a final concentration of 0.5 M NaCl, and
the CD spectra were recorded. As shown in Figure 5C, the addition
of salt partially disrupts the right shift seen for peptide G41CT3,
reducing the wavelength of the occurrence of the minima to 206
FIGURE 5. Concentration dependence of the CD spectra of peptides G41CT3 and G28CT3. Either peptide G41CT3 (A) or peptide G28CT3 (B) was
dissolved in phosphate buffer (pH 7.2) at a final concentration of either 6 (—), 20 (- - -), or 60 (-z-) mM, and the CD spectra were obtained on a JASCO
model J710 spectropolarometer (JASCO, Tokyo, Japan) over a wavelength range of 200 to 250 nm. A step resolution of 0.1 nm and a scan speed of 200
nm/min were employed. Spectra shown are those averaged over a total of 30 accumulations. Molar ellipticity units were calculated using the appropriate
software provided by the manufacturer. In addition, spectra for peptides G41CT3 (C) and G28CT3 (D) were also recorded at 60-mM peptide concentrations
either in the absence (—) or presence (- - -) of added sodium chloride at a final concentration of 0.5 M.
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nm. Thus, the intermolecular interactions between peptide
G41CT3 molecules seen at higher concentrations are at least par-
tially salt sensitive, implying that a significant proportion of these
interactions are of a hydrophilic nature. In contrast, salt had no
disruptive effect on the CD spectrum of a 60-mM concentration of
peptide G28CT3 (Fig. 5D). Rather, a further rightward shift of 2
nm was observed (Fig. 5D). We infer from this that, contrary to
peptide G41CT3, the intermolecular associations observed for
peptide G28CT3 are of a predominantly hydrophobic nature.
The cumulative data from Figure 5 are graphically summarized
in Figure 6.
Thus, although peptides G41CT3 and G28CT3 do not display
any differences either in secondary structure or propensities for it,
they nevertheless show subtle alterations in the way the individual
molecules of these peptides interact with each other when present
at moderately high concentrations.
The kinetics of Ag recognition is also dependent upon peptide
concentration
The biophysical studies described in Figures 5 and 6 were per-
formed in an attempt to rationalize the differences in recognition of
the two peptides G41CT3 and G28CT3 by anti-G41CT3 mAbs.
The only distinction, with respect to behavior in solution, that be-
came apparent from these studies was in the nature of the inter-
molecular interactions that these two peptides are involved in at
higher concentrations. It was of interest, therefore, to determine
whether these differences could account for the observed alteration
in binding behavior. For this purpose, we selected mAb G41.14 as
a representative anti-G41CT3 mAb. A 100-nM concentration of
mAb G41.14 was incubated in the presence of 2, 6, or 20 mM final
concentrations of either peptide G41CT3 or peptide G28CT3, and
the rate of binding was measured as quenching of tryptophan flu-
orescence over a period of 60 min. The resulting slopes obtained
were then plotted against peptide concentrations; the linear regres-
sion fits are shown in Figure 7. An interesting divergence became
evident from these results. While binding rates were only margin-
ally affected with increasing G41CT3 concentrations, indicative of
a true pseudo first order reaction, peptide G28CT3 binding rates
were dramatically influenced (Fig. 7). Surprisingly, at 2-mM con-
centrations, binding rates were comparable for both peptides.
However, peptide G28CT3 became markedly more efficient rela-
tive to peptide G41CT3 at the 6-mM concentration, which was
further enhanced when the peptide concentration was increased to
20 mM (Fig. 7).
The observed concentration-dependent differences between
rates of binding of the peptide analogues to mAb G41.14 correlate
with the observed differences in Figure 5, B and D, supporting the
possibility that the altered nature of intermolecular association
could account for the differential binding rates of peptides G41CT3
and G28CT3 to anti-G41CT3 mAbs.
The ability of peptide G28CT3 to induce B cell-mediated Th1
stimulation correlates with its concentration-dependent
differences in kinetic behavior
Our above-mentioned finding (Fig. 7) that the on-rate of peptide
G28CT3 binding to an anti-G41CT3 mAb was dependent on pep-
tide concentration also prompted us to assess the effect of peptide
dose on relative activation of Th subsets. For this assessment,
G41CT3-primed B cells along with CT3-primed T cells were cul-
tured in the presence of varying amounts of either peptide G41CT3
or G28CT3, and levels of IL-10 and IFN-g, as prototypic Th2 and
Th1 cytokines, respectively, were measured in the culture super-
natants. The results of such an experiment are shown in Figure 8A.
When peptide G41CT3 was employed as recall Ag, the relative
dominance of IL-10 over IFN-g remained invariant over all the
concentrations tested (Fig. 8A). This was, however, not the case for
peptide G28CT3 in which a pronounced IL-10 dominance at low
FIGURE 6. A graphic representation of the data presented in Figure 4.
The shifts in minima of the negative peaks observed for peptides G41CT3
(open circles) and G28CT3 (closed circles) under the various conditions
described in Figure 4 are illustrated here in a graph format.
FIGURE 7. Concentration dependence of the rates of Ab-Ag interac-
tions. A 100-nM final concentration of mAb G41.14 in PBS was mixed
with either 2, 6, or 20 mM final concentrations of either peptide G41CT3
(open circles) or peptide G28CT3 (closed circles), and rates of binding
were measured as described in Materials and Methods. The figure shows
a linear regression plot of slopes obtained at each of these concentrations
vs the concentration employed.
FIGURE 8. Concentration dependence of cytokine profiles induced in
response to either peptide G41CT3 or peptide G28CT3. The protocol em-
ployed was similar to that described for Table I, except that peptide con-
centrations were varied as indicated. A, Levels of IL-10 (, ) and IFN-g
(E, F) produced in culture supernatants in response to varying challenge
concentrations of either peptide G41CT3 (, E) or G28CT3 (, F). B, A
replot of the same data presented for IL-10/IFN-g ratios as a function of
molar concentration with peptide G41CT3 (E) or peptide G28CT3 (F). A
representative of three independent experiments is shown.
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concentrations inverted to IFN-g dominance as the peptide con-
centration was increased (Fig. 8A). These results clearly show that
whereas peptide G28CT3 induced a dose-dependent switch in the
dominance of Th2 to the Th1 type of cytokines, peptide G41CT3
was unable to do so over the concentration range evaluated. Un-
fortunately, higher concentrations could not be tested because both
peptides proved toxic at doses beyond those described (data not
shown).
The dose-dependent Th2 to Th1 switch induced by peptide
G28CT3 was strongly reminiscent of the dose-dependent alter-
ations in its biophysical properties (Figs. 5 and 6), with its conse-
quent influence on the on-rate of peptide binding to an anti-
G41CT3 mAb (Fig. 7). This is exemplified particularly in Figure
8B where we have replotted the data in Figure 8A as ratios of IL-10
to IFN-g at doses relevant to those employed in Figure 7. The
trends observed for both peptides in Figure 8B are clearly consis-
tent with those obtained for concentration-dependent kinetic be-
havior (shown in Fig. 7). Thus, while the IL-10 to IFN-g ratios
elicited by peptide G41CT3 remain relatively unaffected over the
concentration range depicted (Fig. 8B), this is also true of its bind-
ing kinetics (Fig. 7). In contrast, the pronounced bias toward the
Th1-type cytokines seen with increasing peptide G28CT3 concen-
tration (Fig. 8B) correlates exceedingly well with the concentra-
tion-dependent influence on peptide G28CT3 binding kinetics
noted in Figure 7. Collectively, these studies clearly establish a
strong link between the facility of B cell epitope recognition and
the ability of Ag-primed B cells to differentially stimulate the Th1
vs the Th2 subset of Ag-primed Th cells.
Discussion
T cell help for B cells clearly resides in Ag presentation by B cells
and the subsequent display of class II-bound peptides recognized
by specific T cells that ensures cytokine release targeted to Ag-
specific B cells. Although B cells are known to interact with both
subsets (16–18), a number of studies have shown that Ag-present-
ing B cells optimally stimulate the Th2 subset of effector CD4 cells
(19–21). Indeed, it is now generally accepted that while B cell
APCs are biased toward a Th2 response, non-B cell APCs such as
macrophages and dendritic cells drive toward development of Th1
cells (19, 21).
Interesting, new insights have recently been provided that fur-
ther our understanding of APC-driven differential activation of
CD4 effector subsets. For instance, Murray et al. (22) have dem-
onstrated that ligand density available on an APC surface for T cell
recognition plays an important role in promoting relative differ-
entiation of Th subsets. A high ligand density was found to favor
Th1 differentiation, whereas a low ligand density is biased toward
Th2 differentiation (22). Notably, a display of high ligand density
by B cells has also been shown to preferentially stimulate Th1-like
immunity (32). Recent results also suggest that the selective gen-
eration of Th1 vs Th2 effectors may be regulated by the strength of
signal delivered by TCR upon engagement by the MHC class II-
peptide complex on APCs (33). It is therefore now becoming ap-
parent that differentiation/stimulation of CD4 effector subsets is
not rigidly APC restricted, but is also subject to influence by
extraneous parameters. The basis for ligand density-dependent
modulation of CD4 effector pathways has been suggested to
reside in differences in thresholds of activation required for Th1
vs Th2 cells (34).
Our present studies provide further evidence to support a role
for ligands in determining APC-mediated selectivity in Th subset
activation. Here, we employed a pair of analogous peptides, which
although differing in sequence at two positions were nevertheless
previously shown to be invariant with respect to both the fine spec-
ificity of B cells induced and their ability to prime T cells for a
proliferative response (10). Notably, however, peptide G28CT3
proved superior to peptide G41CT3 at inducing a T cell recall
response by G41CT3-primed B cells (10). In this report, we have
extended these observations by demonstrating that, in addition to
quantitative differences, peptides G41CT3 and G28CT3 also in-
duce qualitatively distinct T cell recall responses from a common
pool of Ag-specific T cells. Thus, for example, while an in vitro
challenge of G41CT3-primed LNCs with the homologous peptide
G41CT3 yielded predominantly Th2-type cytokines, a marked en-
hancement of Th1 activation was observed from the same culture
when the recall Ag employed was the heterologous peptide,
G28CT3. Subsequent experiments verified that these differences in
recall abilities was a consequence of G41CT3-primed B cells serv-
ing as APCs. Particularly relevant here was our demonstration that
enriched G41CT3-primed B cells recruited a significantly higher
proportion of Th1 cells from a CT3-primed T cell pool in the
presence of peptide G28CT3 rather than peptide G41CT3. Further,
our observations that neither unprimed B cells nor CT3-primed
LNCs were susceptible to peptide-mediated influences collectively
imply an interaction between primed B cell and the B cell epitope
on Ag as the putative causatory factor for the altered Th recruit-
ment profiles. Finally, the physiologic validity of our in vitro find-
ings was amply demonstrated in adoptive transfer experiments
showing that anamnestic responses of G41CT3-primed B cells
contained an enhanced proportion of the IgG2a isotype of Abs,
relative to IgG1, on boosting with peptide G28CT3 as opposed to
boosting with peptide G41CT3.
The Ag-presenting efficacy of primed B cells is dictated both by
the efficiency of Ag capture through sIg receptors and the effi-
ciency of processing. We have shown earlier that peptides
G28CT3 and G41CT3 do not differ significantly in terms of pro-
cessability subsequent to uptake by APCs (10). This, therefore, left
the possibility that the observed differences in Ag-mediated re-
cruitment of Th subsets could result from differential recognition
of the two peptide Ags by sIg receptors on G41CT3-primed B
cells. Because of the difficulties associated with obtaining large
amounts of G41CT3-primed B cells, we employed anti-G41CT3
mAbs as surrogates for sIgG receptors to probe for differences in
binding properties of peptides G41CT3 and G28CT3. Interest-
ingly, while all mAbs tested displayed comparable affinities for
both peptides, the kinetics of this binding proved to be markedly
different. Significantly higher on-rates of binding were obtained
for peptide G28CT3 relative to peptide G41CT3, although the
magnitude of this difference varied from 3- to 17-fold depending
on the mAb. We believe that the uniformity of these results permits
an extrapolation to suggest that similar differences could also apply
to the sIgG receptors on G41CT3-primed B cells.
Although no significant inherent differences in secondary struc-
tural propensities could be detected between the two peptides, we
were able to identify concentration-dependent alterations in solu-
tion behavior. CD studies in a high ionic strength solution revealed
that the intermolecular associations engaged in by molecules of the
two peptides G41CT3 and G28CT3 at higher concentrations were
of a qualitatively distinct nature. The salt disruptability of associ-
ations seen for peptide G41CT3 was indicative of interactions that
are predominantly hydrophilic (or ionic?). In contrast, the stabi-
lizing effect of salt on the CD spectrum of peptide G28CT3 re-
vealed the occurrence of intermolecular associations that are com-
posed almost exclusively of hydrophobic interactions.
The sole distinction in biophysical properties, detectable as
qualitative differences in the nature of their intermolecular associ-
ations, prompted us to suspect that these differences could also
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account for differences in the binding behavior of the two peptides.
Such a presumption was subsequently confirmed by the results of
an experiment wherein we measured binding rates of both peptides
to an anti-G41CT3 mAb as a function of varying peptide concen-
tration. The rate of peptide G28CT3 binding to the mAb was found
to be profoundly influenced by peptide concentration, with a
marked increase at higher concentrations. In contrast, the binding
rate for peptide G41CT3 was relatively insensitive to concentra-
tion effects with, in fact, a marginal decrease at higher concentra-
tions. The concentration dependence of differences in on-rates of
mAb binding to the two peptides clearly implicates the operation
of concentration-dependent differences in B cell epitope presenta-
tion, which, in turn, may be explained by invoking our results on
the variant nature of the intermolecular association of peptides
G41CT3 and G28CT3. It is possible that the differences in such
weak interactions may be sufficient to alter the kinetics of Ag-Ab
interactions, although too weak to influence equilibrium binding
parameters such as affinity.
Having demonstrated a direct correlation between the kinetics of
Ag binding and the concentration-dependent behavior of peptide
G28CT3 in solution, it remained for us to ascertain whether these
factors could, in fact, be responsible for the altered B cell-mediated
Th subset recruitment profiles by peptide G28CT3 compared with
peptide G41CT3. To verify this, we examined the effect of varying
peptide concentrations on the ability of G41CT3-primed B cells to
elicit Th1- vs Th2-type cytokines from a population of CT3-
primed T cells. The results of these experiments proved extremely
interesting. While relative predominance of the Th2 cytokines was
independent of the dose of peptide G41CT3, a clear transition from
a Th2 to Th1 dominance was observed when peptide G28CT3
concentrations were increased. A comparison of the peptide con-
centrations required for the switch and also of IL-10/IFN-g ratios,
with changes in kinetic and biophysical behavior, all as a function
of increasing peptide concentration, revealed striking similarities.
This strongly suggests an etiologic relationship between alterations
in solution properties of peptide G28CT3, the kinetics of its bind-
ing, and its ability to elicit altered cytokine profiles from a primed
T cell population in the presence of G41CT3-activated B cells.
The mechanism by which the altered nature of intermolecular
associations in peptide G28CT3 promotes binding remains an is-
sue of particular interest. One possibility is that such interactions
render the B cell epitope more accessible to recognition, thereby
increasing the probability of productive collisions leading to a
binding interaction. Alternatively, intermolecular interactions may
also facilitate Th1 recruitment by ensuring simultaneous, multiple
occupancy of recognition sites within either sIg receptors or Ab
molecules, leading in the former case to an increased strength of
the intracellular signal generated. A more definitive conclusion
must, however, await detailed analysis.
Our demonstration here of Ag-induced variability in B cell-me-
diated Th subset activation profiles adds yet another level of in-
tricacy to our current understanding of the processes that mediate
between immune recognition and the qualitative nature of an im-
mune response. It will be particularly interesting to evaluate the
significance of these findings in polarizing effector responses in
infectious disease situations (35). It would also be interesting to
elucidate the mechanism by which the alterations in Ag binding
kinetics by B cells modulate their Ag-presenting properties. At
present, several alternate possibilities may be invoked. For exam-
ple, at an empirical level, an increased rate of binding may simply
correspond to increased Ag uptake, rapidly leading to a high den-
sity of ligand presentation. As discussed earlier, high ligand den-
sities have been proposed to favor Th1 activation (22, 34). A re-
lated factor that also needs consideration stems from the recent
demonstration that the nature of Ag-BCR interaction directly in-
fluences intracellular targeting of Ag to lysozomes, for eventual
processing and presentation (36). While this has been shown to
quantitatively influence T cell activation (36), qualitative distinc-
tions, if any, remain to be examined. Finally, the possibility that
Ag binding kinetics may differentially regulate the extent of B cell
activation—with its consequent effects on up-regulation of one or
more cell surface accessory molecules involved in cognate B-T
interaction (37–41)—also cannot be excluded. Discriminating be-
tween these and perhaps other alternatives is a current emphasis in
our laboratory.
In summary, we have demonstrated here that relative recruit-
ment of Th1 vs Th2 subsets of Ag-activated T cells by Ag-primed
B cells is not invariant but, rather, is modulated by the kinetics of
Ag recognition through its sIg receptor. While the default pathway
is biased toward Th2 recruitment, higher on-rates of binding pro-
mote increased Th1 activation. Also of note is our finding that even
subtle alterations in solution structure, resulting from minor
changes in amino acid sequence, can so markedly influence the
outcome of a cognate interaction between Ag-activated B and T
cells. These findings may also bear implications for molecular
mimicry, wherein homologous B cell epitopes could differentially
skew Th effector responses with the potential for pathogenic con-
sequences if one of the epitopes happens to derive from a self Ag.
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